Taurine 11 pp 471-482 | Cite as

Taurine-Containing Hot Water Extract of Octopus Ocellatus Meat Prevents Methylglyoxal-Induced Vascular Damage

  • Seon-Heui Cha
  • Eui Jeong Han
  • Ginnae Ahn
  • Hee-Sook JunEmail author
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 1155)


Endothelial cell dysfunction (ECD) is a broad term, which implies dysregulation of endothelial cell functions. Several factors contribute to ECD including high blood pressure, high cholesterol levels, diabetes, obesity, hyperglycemia, and advanced glycation end products (AGEs). The highly reactive dicarbonyl methylglyoxal (MGO) is mainly formed as byproduct of glycolysis. Therefore, high blood glucose levels result in increased MGO accumulation. Taurine-rich foods are considered to protect against various diseases including vasculopathy and to exert anti-aging effects. Here, we investigated the protective effect of hot water extract of Octopus ocellatus meat (OOM), which contains high amounts of taurine, on MGO-induced cell damage in human umbilical vein endothelial cells and zebrafish embryos. Hot water extract of OOMinhibited MGO-induced cytotoxicity and DNA damage, as well as AGEs accumulation. In addition, hot water extract of OOM protected against vascular damage in zebrafish embryos. These results suggest that hot water extract of OOM possesses protective activity against MGO-induced cytotoxicity in both umbilical vein endothelial cells and zebrafish embryos. Therefore, it could be used as a dietary source of an agent for the prevention of vascular diseases.


Seaweed Octopus ocellatus meat Octopus ocellatus Diabetic complication Taurine Vascular disease 



advance glycation end products


endothelial cell dysfunction


enhanced green fluorescent protein


human umbilical vein endothelial cells




Octopus ocellatus meat



This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, & Future Planning (2017R1D1A1B03033794, 2016R1A2B2013347).


  1. Ahmed N (2005) Advanced glycation endproducts—role in pathology of diabetic complications. Diabetes Res Clin Pract 67(1):3–21. Scholar
  2. Brambilla G, Sciaba L, Faggin P, Finollo R, Bassi AM, Ferro M, Marinari UM (1985) Methylglyoxal-induced DNA-protein cross-links and cytotoxicity in Chinese hamster ovary cells. Carcinogenesis 6(5):683–686CrossRefGoogle Scholar
  3. Cha S-H, Lee J-H, Kim E-A, Shin CH, Jun H-S, Jeon Y-J (2017) Phloroglucinol accelerates the regeneration of liver damaged by H2O2 or MNZ treatment in zebrafish. RSC Adv 7(73):46164–46170. Scholar
  4. Desai KM, Chang T, Wang H, Banigesh A, Dhar A, Liu J, Untereiner A, Wu L (2010) Oxidative stress and aging: is methylglyoxal the hidden enemy? Can J Physiol Pharmacol 88(3):273–284. Scholar
  5. Fowler MJ (2008) Microvascular and macrovascular complications of diabetes. Clin Diabetes 26(2):77–82. Scholar
  6. Fukami K, Yamagishi S, Ueda S, Okuda S (2008) Role of AGEs in diabetic nephropathy. Curr Pharm Des 14(10):946–952CrossRefGoogle Scholar
  7. Giacco F, Brownlee M (2010) Oxidative stress and diabetic complications. Circ Res 107(9):1058–1070. Scholar
  8. Goligorsky MS (2005) Endothelial cell dysfunction: can’t live with it, how to live without it. Am J Physiol Renal Physiol 288(5):F871–F880. Scholar
  9. Hadi HA, Suwaidi JA (2007) Endothelial dysfunction in diabetes mellitus. Vasc Health Risk Manag 3(6):853–876PubMedPubMedCentralGoogle Scholar
  10. Hansen SH (2001) The role of taurine in diabetes and the development of diabetic complications. Diabetes Metab Res Rev 17(5):330–346CrossRefGoogle Scholar
  11. Horie K, Miyata T, Maeda K, Miyata S, Sugiyama S, Sakai H, van Ypersole de Strihou C, Monnier VM, Witztum JL, Kurokawa K (1997) Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J Clin Invest 100(12):2995–3004. Scholar
  12. Ito T, Schaffer SW, Azuma J (2012) The potential usefulness of taurine on diabetes mellitus and its complications. Amino Acids 42(5):1529–1539. Scholar
  13. Jong CJ, Azuma J, Schaffer S (2012) Mechanism underlying the antioxidant activity of taurine: prevention of mitochondrial oxidant production. Amino Acids 42(6):2223–2232. Scholar
  14. Kang JH (2003) Oxidative damage of DNA induced by methylglyoxal in vitro. Toxicol Lett 145(2):181–187CrossRefGoogle Scholar
  15. Maclean KN, Jiang H, Aivazidis S, Kim E, Shearn CT, Harris PS, Petersen DR, Allen RH, Stabler SP, Roede JR (2018) Taurine treatment prevents derangement of the hepatic gamma-glutamyl cycle and methylglyoxal metabolism in a mouse model of classical homocystinuria: regulatory crosstalk between thiol and sulfinic acid metabolism. FASEB J 32(3):1265–1280. Scholar
  16. Militante JD, Lombardini JB (2002) Treatment of hypertension with oral taurine: experimental and clinical studies. Amino Acids 23(4):381–393. Scholar
  17. Militante JD, Lombardini JB, Schaffer SW (2000) The role of taurine in the pathogenesis of the cardiomyopathy of insulin-dependent diabetes mellitus. Cardiovasc Res 46(3):393–402CrossRefGoogle Scholar
  18. Moloney MA, Kelly JJ, Condron CM, Roche-Nagle G, O’Donnell DH, Fennessy FM, Bouchier-Hayes DJ (2003) Taurine supplementation reverses endothelial cell dysfunction and promotes mobilisation of endothelial progenitor cells. J Surg Res 114(2):298–299. Scholar
  19. Samarakoon et al (2013) The growth, innate immunity and protection against H 2 O 2 - induced oxidative damage of a chitosan-coated diet in the olive flounder paralichthys olivaceus. J Fish Aquat Sci 16(3):149–158CrossRefGoogle Scholar
  20. Singh VP, Bali A, Singh N, Jaggi AS (2014) Advanced Glycation end products and diabetic complications. Kor J Physiol Pharmacol 18(1):1–14. Scholar
  21. Sree SL, Sethupathy S (2014) Evaluation of the efficacy of taurine as an antioxidant in the management of patients with chronic periodontitis. Dent Res J 11(2):228–233Google Scholar
  22. Stitt AW, Moore JE, Sharkey JA, Murphy G, Simpson DA, Bucala R, Vlassara H, Archer DB (1998) Advanced glycation end products in vitreous: structural and functional implications for diabetic vitreopathy. Invest Ophthalmol Vis Sci 39(13):2517–2523PubMedGoogle Scholar
  23. Vulesevic B, McNeill B, Giacco F, Maeda K, Blackburn NJR, Brownlee M, Milne RW, Suuronen EJ (2016) Methylglyoxal-induced endothelial cell loss and inflammation contribute to the development of diabetic cardiomyopathy. Diabetes 65(6):1699–1713. Scholar
  24. Xu J, Zou MH (2009) Molecular insights and therapeutic targets for diabetic endothelial dysfunction. Circulation 120(13):1266–1286. Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Seon-Heui Cha
    • 1
  • Eui Jeong Han
    • 2
  • Ginnae Ahn
    • 3
    • 4
  • Hee-Sook Jun
    • 5
    Email author
  1. 1.Department of Marine BioindustryHanseo UniversitySeosanRepublic of Korea
  2. 2.Department of Food Technology and Nutrition, Department of Marine Bio-Food SciencesChonnam National UniversityYeosuRepublic of Korea
  3. 3.Department of Food Technology and NutritionChonnam National UniversityYeosuRepublic of Korea
  4. 4.Department of Marine Bio-Food SciencesChonnam National UniversityYeosuRepublic of Korea
  5. 5.Gachon Medical Research Institute, Gil HospitalIncheonRepublic of Korea

Personalised recommendations